Luminari CRO Launches Revolutionary AI-Powered Platform to Transform Clinical Trial Efficiency and Drug Development
Summary
Luminari CRO has launched an AI-powered platform aimed at improving clinical trial efficiency and drug development. The company says its technology uses virtual patient models and predictive analytics to speed protocol design, reduce trial failures, and improve recruitment. It is also opening a $2 million pre-seed round and partnering with 20/15 Visioneers to support scientific validation and go-to-market efforts. The company positions the platform as a way for pharmaceutical sponsors to cut costs, shorten timelines, and accelerate treatment delivery.
Funding
Amount
$2.0M
Total raised
Date
September 5, 2025
Announcement date
Investors
-
Lead investors
Company
https://luminaricro.com
Funded company
Classifications
industries
HealthTech
applications
Data Management
AskAI Classifications
Labels
SaaS
Artificial Intelligence Software
Clinical Trial Software
Linked Companies
Luminari CRO
up to $1M